Adoptive Immunotherapy for Posttransplant Ebv Lymphoma

Lucas, Kenneth G.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project (R01)
• Project #: 7R01CA075566-02
• Application #: 2717151
• Study Section: Special Emphasis Panel (ZCA1-CRB-X (M1))
• Project Start: 1997-09-01
• Project End: 2001-08-31
• Budget Start: 1998-02-01
• Budget End: 1998-08-31
• Support Year: 2
• Fiscal Year: 1997

Institution

• Name: University of Alabama Birmingham
• Department: Pediatrics
• Type: Schools of Medicine
• DUNS #: 004514360
• City: Birmingham
• State: AL
• Country: United States
• Zip Code: 35294

Publications

Sun, Qi; Burton, Robert L; Lucas, Kenneth G (2002) Cytokine production and cytolytic mechanism of CD4(+) cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures. Blood 99:3302-9

Sun, Qi; Burton, Robert; Reddy, Vishnu et al. (2002) Safety of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma. Br J Haematol 118:799-808

Sun, Q; Burton, R L; Dai, L J et al. (2000) B lymphoblastoid cell lines as efficient APC to elicit CD8+ T cell responses against a cytomegalovirus antigen. J Immunol 165:4105-11

Sun, Q; Pollok, K E; Burton, R L et al. (1999) Simultaneous ex vivo expansion of cytomegalovirus and Epstein-Barr virus-specific cytotoxic T lymphocytes using B-lymphoblastoid cell lines expressing cytomegalovirus pp65. Blood 94:3242-50

Sun, Q; Burton, R L; Pollok, K E et al. (1999) CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood. Cell Immunol 195:81-8